PAR

3.92%

24.5¢ paradigm biopharmaceuticals limited..

LJSM, I’d have to go back and find the exact presentation from...

First 114 Last

Share
Profile

Follow
Whitta

399 Posts.

23

09/04/24

16:10

Post #: 73261599
Share

Originally posted by LJSM: ↑

Stressful again getting toward recent lows. I've seen some biotechs go to zero, one in particular where I believe the CEO was incompetent in keeping funding going at a critical stage. It could happen with PAR but I don't see it at this stage.
Current dealings with the FDA need to be finalized and things will be clearer - time-frames, numbers, key measures and perhaps a general view from the FDA (hopefully supportive?) The time will be mainly driven by the FDA IMO but PAR may not help the cause if they get a little cheeky in trying to get any leeway in terms of numbers, time, measures etc. This stuff can take months so the issue again falls back to PR and his commentary for those feeling time is getting on.
So I wait for clarity. Funding will then be a priority but easier whatever the outcome from the FDA IMO. It could be highly dilutive but they should be able to raise.
Then for me a new independent Chair. I have some scepticism around recent appointment's- they have insider knowledge on their holdings and clients holdings -maybe no big deal if everyone is honest and open?? Once a Chair is appointed, I would be flabbergasted to see PR remain in a senior role, certainly not CEO. He's the only webinar presenter I've seen run out of time (not for questions either, actual presentation). His prior interview, he looked like he pulled a top out of the laundry basket or came in from the garden?? May seem picky but PAR needs better IMO.
Not happy but it's certainly got plenty of life.

Expand

LJSM, I’d have to go back and find the exact presentation from PR, but he did one about 4 or 5 years ago in a T-shirt.
so I guess recent presentations are better than they were at one point.

PAR Price at posting: 30.5¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

HVN

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

CYM

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

PYC

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

LLC

Lendlease sells off US east coast construction operations in latest global divestment push

CCO

The Calmer Co’s Anthony Noble reflects on record breaking FY24

HLX

Helix investor makes partial takeover bid, proposing board changes

TBN

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

VYS

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

There are more pages in this discussion • 593 more messages in this thread...

First 114 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 24.5¢		Change -0.010(3.92%)		Mkt cap ! $85.70M

Open	High	Low	Value	Volume
24.5¢	25.0¢	24.0¢	$59.66K	241.2K

Buyers (Bids)

No.	Vol.	Price($)
4	78837	24.5¢

Sellers (Offers)

Price($)	Vol.	No.
25.0¢	36290	1

View Market Depth

No.	Vol.	Price($)
4	78837	0.245
3	44840	0.240
5	111000	0.235
5	125200	0.230
6	135884	0.225

Price($)	Vol.	No.
0.255	46689	5
0.260	106349	3
0.265	30000	1
0.270	20000	2
0.275	13636	2

Last trade - 16.10pm 30/08/2024 (20 minute delay)

PAR (ASX) Chart

LJSM, I’d have to go back and find the exact presentation from...

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Lendlease sells off US east coast construction operations in latest global divestment push

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Helix investor makes partial takeover bid, proposing board changes

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

LJSM, I’d have to go back and find the exact presentation from...

Top Stories

Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch

Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24

WA Nifty copper project steps closer to restart with Cyprium Metals inking $40M loan from Glencore

PYC achieves key designation for drug aiming to treat blinding eye disease ADOA

Lendlease sells off US east coast construction operations in latest global divestment push

The Calmer Co’s Anthony Noble reflects on record breaking FY24

Helix investor makes partial takeover bid, proposing board changes

Tamboran kicks off Shenandoah South pilot project with SS-2H well spud

Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip

Vysarn acquires Waste Water Services Pty Ltd for $7.5M; WWS to become subsidiary as expansion continues

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News